Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States

from Value in Health at http://bit.ly/2YWQwsb on May 31, 2019 at 11:27AM

Publication date: Available online 31 May 2019

Source: Value in Health

Author(s):